相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Subtype-Specific Peripheral Blood Gene Expression Profiles in Recent-Onset Juvenile Idiopathic Arthritis
Michael G. Barnes et al.
ARTHRITIS AND RHEUMATISM (2009)
Gene Expression Signatures in Polyarticular Juvenile Idiopathic Arthritis Demonstrate Disease Heterogeneity and Offer a Molecular Classification of Disease Subsets
Thomas A. Griffin et al.
ARTHRITIS AND RHEUMATISM (2009)
Pediatric drug surveillance and the food and drug administration's adverse event reporting system: an overview of reports, 2003-2007
Rosemary Johann-Liang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease
David Burgner et al.
PLOS GENETICS (2009)
Lack of Interaction of the NMDA Receptor Antagonists Dextromethorphan and Dextrorphan with P-Glycoprotein
Jules Desmeules et al.
CURRENT DRUG METABOLISM (2008)
Developmental changes in human liver CYP2D6 expression
Jeffrey C. Stevens et al.
DRUG METABOLISM AND DISPOSITION (2008)
Pediatric rheumatology for the adult rheumatologist
Linda Wagner-Weiner
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease
Subra Kugathasan et al.
NATURE GENETICS (2008)
Postmenstrual age and CYP2D6 polymorphisms determine tramadol O-demethylation in critically I11 neonates and infants
Karel Allegaert et al.
PEDIATRIC RESEARCH (2008)
Cough and cold medication use by US children, 1999-2006: Results from the Slone Survey
Louis Vernacchio et al.
PEDIATRICS (2008)
Unexpected infant deaths associated with use of cough and cold medications
Mary E. Rimsza et al.
PEDIATRICS (2008)
Improving pediatric dosing through pediatric initiatives: What we have learned
William Rodriguez et al.
PEDIATRICS (2008)
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Ronald N. Hines
PHARMACOLOGY & THERAPEUTICS (2008)
Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients
I. Rudberg et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Over-the-counter medications for acute cough in children and adults in ambulatory settings
S. M. Smith et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Miriam F. Moffatt et al.
NATURE (2007)
Ontogeny of dextromethorphan O- and N-demethylation in the first year of life
M. J. Blake et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: Dextromethorphan as a model application
Gemma L. Dickinson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Identification of human cytochrome P450 isozymes involved in diphenhydramine N-demethylation
Tomoko Akutsu et al.
DRUG METABOLISM AND DISPOSITION (2007)
Impact of CYP2D6*10 on H1-antihistamine-induced hypersomnia
Junji Saruwatari et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
O-demethylation of tramadol in the first months of life
K Allegaert et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Tramadol disposition in the very young:: an attempt to assess in vivo cytochrome P-450 2D6 activity
K Allegaert et al.
BRITISH JOURNAL OF ANAESTHESIA (2005)
Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance
S Borges et al.
DRUG METABOLISM AND DISPOSITION (2005)
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
M Ingelman-Sundberg
PHARMACOGENOMICS JOURNAL (2005)
Developmental expression of human hepatic CYP2C9 and CYP2C19
SB Koukouritaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Elimination of ephedrines in urine following multiple dosing: The consequences for athletes, in relation to doping control
N Chester et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
UM Zanger et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers
LE Pope et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Pediatric drug labeling - Improving the safety and efficacy of pediatric therapies
R Roberts et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Developmental and pediatric pharmacogenomics
JS Leeder
PHARMACOGENOMICS (2003)
P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists
CP Chen et al.
DRUG METABOLISM AND DISPOSITION (2003)
The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine
SU Yasuda et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Inhibitory effects of H1-antihistamines on CYP2D6-and CYP2C9-mediated drug metabolic reactions in human liver microsomes
N He et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans
É Lessard et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics
DW Nebert
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity
BA Hamelin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
